Anavex Life Sciences Corp (AVXL)

[Doktornolittle]

WWayne asked, ""CM - The outcome of the Phase 2a will determine what the best "ratio" might be if data confirms preclinical findings of synergy with donepezil. Anavex could develop a proprietary new formulation or a standard combination depending on the findings of Phase 2a."

Thoughts about the proprietary formulation?"

What I thought they meant was they will either put the optimum ratio in there own single pill (which would be a proprietary pill) or have a recommended dose of Donezepzil to be take with their dose of 273; seperate pills.

The single pill would have the advantage of being less likely to forget which matters for everyone but especially Alzheimer's patients. The two pill approach has the advantage that that they don't have to be taken at the same time, but rather, an optimum sequence might be found.

Another advantage to a single pill would be that they would have more control of pricing on the generic Donepezil side. That would help them in negotiating reimbursement with medicare. It would be less of a circus.